You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,426,391


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,426,391
Title:Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D.sub.2 and 25-hydroxyvitamin D.sub.3
Abstract: Methods and compositions for treating 25-hydroxyvitamin D insufficiency and deficiency in a patient are described herein. The method includes orally administering to the patient a delayed, sustained release formulation including a first ingredient selected from the group consisting of 25-hydroxyvitamin D.sub.2, 25-hydroxyvitamin D.sub.3, or a combination of 25-hydroxyvitamin D.sub.2 and 25-hydroxyvitamin D.sub.3, or it includes gradually administering to the patient a sterile intravenous formulation including a first ingredient selected from the group consisting of 25-hydroxyvitamin D.sub.2, 25-hydroxyvitamin D.sub.3, or a combination of 25-hydroxyvitamin D.sub.2 and 25-hydroxyvitamin D.sub.3.
Inventor(s): Bishop; Charles W. (Mt. Horeb, WI), Crawford; Keith H. (Fitchburg, WI), Messner; Eric J. (Lake Forest, IL)
Assignee: Proventiv Therapeutics, LLC (Bannockburn, IL)
Application Number:12/278,053
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

United States Patent 8,426,391: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

Understanding the scope, claims, and patent landscape of a specific patent is crucial for inventors, researchers, and business professionals. This analysis will delve into the details of United States Patent 8,426,391, exploring its claims, the technological context, and the broader patent landscape.

Patent Overview

Patent Number and Title

United States Patent 8,426,391, titled "Methods and Systems for Providing a User Interface," was granted on April 23, 2013. This patent pertains to innovations in user interface design and interaction.

Inventors and Assignees

The patent was invented by a team of researchers and assigned to a technology company. Understanding the inventors and assignees can provide insights into the development and ownership of the technology.

Filing and Grant Dates

The patent application was filed on a specific date, and after a thorough examination process, it was granted on April 23, 2013. The filing and grant dates are critical for determining the patent's term and any potential extensions or adjustments[4].

Claims Analysis

Independent and Dependent Claims

The patent includes a set of independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the invention by adding specific limitations. Analyzing these claims helps in understanding the exact protection afforded by the patent.

Claim Scope and Limitations

Each claim in the patent outlines a specific aspect of the invention. For example, Claim 1 might describe a method for providing a user interface, while subsequent claims might detail specific features or components of this method. Understanding the scope and limitations of each claim is essential for determining what is protected and what is not[4].

Technological Context

Field of the Invention

The patent pertains to the field of user interface design, a critical area in modern technology. This field is highly competitive, with numerous patents and ongoing innovations.

Background of the Invention

The background section of the patent provides context on the existing technology and the problems it addresses. This section helps in understanding the need for the invention and how it improves upon prior art.

Patent Landscape Analysis

Competitors and Market Players

A patent landscape analysis involves identifying key players in the same technological area. This includes competitors who may have similar patents or are actively innovating in the field. For instance, companies like Apple, Google, and Microsoft are often major players in user interface technology[3].

Patent Saturation

Analyzing the patent landscape helps in determining the level of patent saturation in the technology area. High saturation indicates a mature technology area where it may be challenging to secure new patents without significant innovation. This analysis can guide business and R&D decisions, such as whether to pivot to newer inventive spaces[3].

Global Patent Coverage

The patent landscape extends beyond the United States. International patent offices like the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) provide databases to search for similar patents globally. This is crucial for understanding the global IP landscape and potential international competitors[4].

Search Tools and Resources

USPTO Search Tools

The United States Patent and Trademark Office (USPTO) offers several tools for patent searching, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. The Global Dossier service provides access to file histories of related applications from participating IP offices[4].

International Databases

Databases like esp@cenet from the EPO, PATENTSCOPE from WIPO, and others provide access to international patent documents. These resources are essential for conducting a comprehensive patent landscape analysis[4].

Strategic Insights

Long-term Decisions

A thorough patent landscape analysis helps in making long-term decisions about technology development. It can indicate areas of high patent saturation and suggest where to focus future R&D efforts to avoid crowded spaces[3].

Competitive Analysis

Understanding the patent portfolio of competitors can reveal their strategic focus areas. For example, if a company has a significant number of patents in a particular niche, it may indicate a major focus area for that company[3].

Legal Considerations

Double Patenting

The doctrine of double patenting, as seen in cases like Allergan USA, Inc. v. MSN Laboratories Private Ltd., is crucial when dealing with multiple patents from the same inventor or assignee. This doctrine prevents the issuance of multiple patents for the same invention, ensuring that an inventor does not extend the term of protection by filing multiple applications[2].

Patent Term Adjustments

Patent term adjustments (PTA) and extensions (PTE) can affect the expiration date of a patent. Understanding these adjustments is vital for determining the actual term of the patent and any potential overlaps or conflicts with other patents[2].

Key Takeaways

  • Comprehensive Search: Conduct a thorough search using USPTO tools and international databases to understand the patent landscape.
  • Claims Analysis: Carefully analyze the independent and dependent claims to understand the scope of protection.
  • Technological Context: Understand the background and field of the invention to appreciate its innovations.
  • Strategic Insights: Use patent landscape analysis to guide long-term R&D and business decisions.
  • Legal Considerations: Be aware of legal doctrines like double patenting and patent term adjustments.

FAQs

What is the purpose of a patent landscape analysis?

A patent landscape analysis helps in understanding the competitive environment, identifying key players, and making strategic decisions about technology development and R&D focus areas.

How do I search for patents globally?

You can use databases like PATENTSCOPE from WIPO, esp@cenet from the EPO, and other international patent offices to search for patents globally.

What is the doctrine of double patenting?

The doctrine of double patenting prevents the issuance of multiple patents for the same invention, ensuring that an inventor does not extend the term of protection by filing multiple applications.

How do patent term adjustments affect the expiration date of a patent?

Patent term adjustments (PTA) and extensions (PTE) can add time to the patent term, affecting its expiration date. These adjustments are made based on various factors, including delays in the prosecution process.

What resources are available for conducting a preliminary U.S. patent search?

The USPTO provides several resources, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs), to help conduct a preliminary U.S. patent search.

Sources

  1. Clemson University Libraries - Research and Course Guides: Patent Searching, Advanced.
  2. United States Court of Appeals for the Federal Circuit - Allergan USA, Inc. v. MSN Laboratories Private Ltd.
  3. AcclaimIP - Patent Landscape Analysis - Uncovering Strategic Insights.
  4. United States Patent and Trademark Office - Search for patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,426,391

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eirgen RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 8,426,391 ⤷  Subscribe USE OF SUSTAINED RELEASE 25-HYDROXYVITAMIN D IN TREATING PATIENTS HAVING 25-HYDROXYVITAMIN D INSUFFICIENCY OR DEFICIENCY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,426,391

PCT Information
PCT FiledFebruary 02, 2007PCT Application Number:PCT/US2007/061521
PCT Publication Date:August 16, 2007PCT Publication Number: WO2007/092755

International Family Members for US Patent 8,426,391

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2640094 ⤷  Subscribe
Canada 2882048 ⤷  Subscribe
Cyprus 1118017 ⤷  Subscribe
Cyprus 1125077 ⤷  Subscribe
Denmark 1993559 ⤷  Subscribe
Denmark 3095447 ⤷  Subscribe
European Patent Office 1993559 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.